John T. Treace, Chief Executive Offer at TREACE MEDICAL CONCEPTS, INC. (TMCI), sold 4,150 shares at $24.41 ($101K) on 2023-03-09, disclosed to the SEC on 2023-03-10.
Open-market sale of $101k TMCI by Chief Executive Offer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $24.41 | 2,075 | $51K | 50.0% |
| 2 | $24.41 | 2,075 | $51K | 50.0% |
| Total | $24.41 avg | 4,150 | $101K | 100% |
| Filing → |
| TMCI | BUY | 2026-06-11 | $211K | — | Filing → |
| TMCI | BUY | 2026-06-01 | $178K | — | Filing → |
| TMCI | BUY | 2026-05-28 | $341K | — | Filing → |